Mr Mark Rochester: Urology

Home
Mr Mark Rochester

Fee assured
Verified this account

Overview

Specialises in

General

Urological malignancy

About me

Mr Rochester qualified from Trinity College, Cambridge in 1998 with first class honours in medical sciences. After surgical training in Oxford he undertook a period of full-time laboratory research in urological oncology at the Institute of Molecular Medicine in Oxford which led to the award of an MD degree and election to the post of Royal College of Surgeons of England Hunterian Professor in 2006. His specialist urology training took place in the Eastern Deanery, predominantly in Norwich and Cambridge. Mr Rochester has subspecialty training in urological cancer surgery, particularly for the kidney and bladder and offers minimally invasive (robotic and laparoscopic) surgery for these conditions - laparoscopic cystectomy, radical and partial nephrectomy. He also has expertise in Holmium laser enucleation for the prostate (HoLEP/laser prostatectomy) for benign prostate enlargement and the Urolift procedure. He is currently the clinical lead for Urology at Norfolk and Norwich University Hospital.

Areas of interest

Laser prostatectomy (HoLEP); Urolift; Bladder cancer; Benign prostatic hyperplasia (BPH); Kidney (renal) cancer; Prostate disease including prostate cancer; Urological oncology; Laparoscopic procedures ('keyhole surgery'); Robotic surgery, Haematuria; Urinary tract disorders

Medical secretaries

Hilary Whitehouse
Norfolk & Norwich University Hospital Colney Lane Colney NORWICH NR4 7UY
01603 287453
01603 287884
hilary.whitehouse@nnuh.nhs.uk

Anaesthetists worked with (Bupa members, please ask your consultant whether your anaesthetist is fee-assured)

Dr Robert J Harwood

Dr Paul J Hutchings

Dr Philip E Hodgson

About me

External resources

Current NHS consultant posts held

Consultant Urological Surgeon & Clinical Director
Norfolk and Norwich University Hospital

Research interests

Kidney, prostate and bladder cancer

Preoperative exercise interventions, CPEX testing

Personal interests

Mr Rochester is married with three daughters

Awards received

Regional Innovation Award 2010
Royal College of Surgeons Hunterian Professorship 2006
NICE Shared Learning Awards Commendation 2017

Publications

Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing. Manson-Bahr D, Ball R, Gundem G, Sethia K, Mills R, Rochester M, et al J Clin Pathol. 2015 Mar;68(3):212-7

Prediction of complications after partial nephrectomy by RENAL nephrometry score.
Reddy UD, Pillai R, Parker RA, Weston J, Burgess NA, Ho ET, Mills RD, Rochester MA. Ann R Coll Surg Engl. 2014

Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing trans-rectal prostate biopsy in Norwich, UK.
Yazbek Hanna M, Tremlett C, Josan G, Eltom A, Mills R, Rochester M, Livermore DM. BJU Int. 2014 Jul 31.

Nephroureterectomy surgery in the United Kingdom in 2012: British Association of Urological Surgeons (BAUS) Registry data. Connolly SS, Rochester MA; B.A.U.S..BJU Int. 2014

Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks. Turney BW, Kerr M, Chitnis MM, Lodhia K, Wang Y, Riedemann J, Rochester M, Protheroe AS, Brewster SF, Macaulay VM. Radiother Oncol. 2012 Jun;103(3):402-9.

Self Management Activation Randomised Trial for Prostatitis (SMART-P): study protocol for a randomised controlled trial. Rochester M et al. Trials. 2011

A prospective randomised trial of extended core prostate biopsy protocols utilizing 12 versus 15 cores. Rochester MA, et al J. Urol Int. 2009

Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population.
Rochester MA, et al BMC Urol. 2009

A randomised trial of conventional versus BAUS procedure-specific consent forms for transurethral resection of prostate.
Finch WJ, Rochester MA, Mills RD. Ann R Coll Surg Engl. 2009

Prospective evaluation of a novel one-stop testicular clinic.
Rochester M, et al Ann R Coll Surg Engl. 2008

The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer.
Rochester MA, et al BJU Int. 2007

Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer. Patel NS, Dobbie MS, Rochester M, Steers G, Poulsom R, Le Monnier K, Cranston DW, Li JL, Harris AL.
Clin Cancer Res. 2006

A double-blind, randomized, controlled trial of topical glyceryl trinitrate for transrectal ultrasound guided prostate biopsy. Rochester MA, Le Monnier K, Brewster SF.
J Urol. 2005

My outcomes

My qualifications & training

My private practice

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

M4510
Diagnostic endoscopic examination of bladder (flexible cystoscopy) including any biopsy - (5-50)

(1-5)
M6533
Holmium Laser Enucleation of Prostatic Adenoma (HoLEP) - (5-50)

(1-5)
T4300
Laparoscopic adhesiolysis (including biopsy) - (1-5)
B2233
Adrenalectomy - unilateral (laparoscopic) - (1-5)
N1100
Correction of hydrocele(s) - unilateral - (1-5)

(1-5)
M8130
External meatotomy of urethral orifice - (1-5)
M0303
Robotic assisted laparoscopic partial nephrectomy - (1-5)
M3410
Robotic assisted laparoscopic cystectomy without prostatectomy (with construction of intestinal conduit or bladder) - (1-5)

(1-5)
N1580
Excision of epididymal cyst - (1-5)
M4320
Endoscopic hydrostatic distension of bladder (including cystoscopy) - (1-5)
Show All (10)...

Print page

Consultant and
Facilities Finder

Note: